TherapeuticsMD (TXMD) Shares Outstanding (Entity) (2010 - 2026)
TherapeuticsMD (TXMD) posted Shares Outstanding (Entity) of 11.57 million for Q2 2026, unchanged from 11.57 million a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Since Q2 2010, TherapeuticsMD has reported Shares Outstanding (Entity) for 64 quarters.
- Annual Shares Outstanding (Entity) shows a five-year compound annual growth rate of -47.8% (FY2020 to FY2025).
- In prior years, TherapeuticsMD's Shares Outstanding (Entity) was 11.53 million in FY2024 (unchanged), 11.53 million in FY2023 (+21.4%), 9.5 million in FY2022 (-97.8%) and 429.89 million in FY2021 (+43.4%).
- Quarterly Shares Outstanding (Entity) has run from a low of 8.67 million in Q1 2022 to a high of 429.89 million in Q4 2021 over five years.
- On a year-over-year basis, Shares Outstanding (Entity) increased in five of the last seven quarters, with growth averaging 1.5%.
- The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q3 2021, with growth of 55.7%; the weakest was Q1 2022, with a decline of 97.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 11.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.57 Mn |
| Dec 31, 2025 | 11.57 Mn |
| Sep 30, 2025 | 11.57 Mn |
| Jun 30, 2025 | 11.57 Mn |
| Mar 31, 2025 | 11.57 Mn |
| Dec 31, 2024 | 11.53 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 11.53 Mn |
| Mar 31, 2024 | 11.53 Mn |
| Dec 31, 2023 | 11.53 Mn |
| Sep 30, 2023 | 10.58 Mn |
| Jun 30, 2023 | 10.58 Mn |
| Mar 31, 2023 | 9.55 Mn |
| Dec 31, 2022 | 9.50 Mn |
| Sep 30, 2022 | 9.47 Mn |
| Jun 30, 2022 | 8.86 Mn |
| Mar 31, 2022 | 8.67 Mn |
| Dec 31, 2021 | 429.89 Mn |
| Sep 30, 2021 | 424.88 Mn |
| Jun 30, 2021 | 395.05 Mn |
API Access
TherapeuticsMD Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();